Replies to post #294 on Cypress Bioscience Inc (CYPB)

[eastunder]

Extending it, eh? Guess they need more time to take over the world. ;)

approximately 2,077,707 shares of Common Stock of Cypress, representing approximately 5.4% of all outstanding shares, were validly tendered.

What happened to all those disgruntled shareholders? 5.4% isn't the mass of people they counted on.

[eastunder]

Ramius Extends Tender Offer to Acquire Cypress (AGAIN)

(Note: Until 12-10-10 Midnight this time)

http://finance.yahoo.com/news/Ramius-Extends-Tender-Offer-prnews-788593323.html?x=0&.v=1

Press Release Source: Ramius LLC On Tuesday November 2, 2010, 5:45 pm EDT

NEW YORK, Nov. 2, 2010 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it is extending its previously announced tender offer for all outstanding shares of common stock of Cypress Bioscience, Inc. ("Cypress" or "the Company") (Nasdaq:CYPB - News) until 12:00 Midnight, New York City time, on December 10, 2010, unless the offer is further extended. The tender offer was previously scheduled to expire at 12:00 Midnight, New York City time, on November 10, 2010. All other material terms and conditions of the tender offer remain unchanged.

As of the close of business on November 1, 2010, approximately 2,098,955 shares of Common Stock of Cypress, representing approximately 5.4% of all outstanding shares, were validly tendered and not withdrawn pursuant to the tender offer. This amount does not include the 3,815,000 shares owned by Ramius and its affiliates.

On September 15, 2010, Ramius announced that it commenced a tender offer to acquire all of the outstanding shares of common stock of Cypress for $4.25 per share in cash. This offer represents a 70% premium over the $2.50 closing price of Cypress' stock on July 16, 2010, the last trading day before Ramius publicly announced its proposal to acquire the Company for $4.00 per share in cash.

Ramius has entered into a confidentiality agreement with Cypress to conduct due diligence in connection with its tender offer or a possible negotiated transaction with Cypress. The confidentiality agreement does not restrict Ramius' ability to continue or consummate its current tender offer or to conduct a proxy solicitation in connection with the Company's 2011 Annual Meeting of Stockholders.

Innisfree M&A Incorporated is acting as information agent for Ramius' offer and Olshan Grundman Frome Rosenzweig & Wolosky LLP is acting as legal counsel to Ramius.